These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 4085300)

  • 21. [Pathogenesis of certain complications in intrauterine contraception and their prevention].
    Matspanova OD
    Vopr Okhr Materin Det; 1974 Dec; 19(12):54-6. PubMed ID: 4612969
    [No Abstract]   [Full Text] [Related]  

  • 22. Preventive treatment of intrauterine device-induced menstrual blood loss with tranexamic acid in Chinese women.
    Lin X; Gao ES; Li D; Zhang M; Dou LX; Yuan W
    Acta Obstet Gynecol Scand; 2007; 86(9):1126-9. PubMed ID: 17712656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Complications and failures of using intrauterine contraceptive devices].
    Botiuk K
    Ginekol Pol; 1985 Jan; 56(1):5-8. PubMed ID: 4018627
    [No Abstract]   [Full Text] [Related]  

  • 24. [Editorial: Intrauterine devices].
    Dolvik H
    Tidsskr Nor Laegeforen; 1974 Nov; 94(31):2179-80. PubMed ID: 4428481
    [No Abstract]   [Full Text] [Related]  

  • 25. Menorrhagia with intrauterine contraceptive devices.
    Fulton DI; Hughes R; Neely MR
    J Obstet Gynaecol Br Commonw; 1967 Oct; 74(5):766-7. PubMed ID: 6058543
    [No Abstract]   [Full Text] [Related]  

  • 26. Increased endometrial fibrinolytic activity as a cause of menometrorrhagia in women using IUD's.
    Surico N; Tavassoli K; Porcelli A; Ferraris G
    Panminerva Med; 1988; 30(3):184-7. PubMed ID: 3211578
    [No Abstract]   [Full Text] [Related]  

  • 27. Letter: Menorrhagia and intrauterine devices.
    Harrison RF
    Lancet; 1976 Apr; 1(7963):803. PubMed ID: 56611
    [No Abstract]   [Full Text] [Related]  

  • 28. [A new intrauterine device].
    Ingemanson CA
    Lakartidningen; 1971 Dec; 68(51):5928-30. PubMed ID: 5139545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of tranexamic acid (AMCA) in menorrhagia with intrauterine contraceptive devices.
    Weström L; Bengtsson LP
    J Reprod Med; 1970 Oct; 5(4):154-61. PubMed ID: 4940818
    [No Abstract]   [Full Text] [Related]  

  • 30. [A non-hormonal therapeutic agent in menorrhagia. Clinical trial of Daflon].
    Darmaillacq R; Sentenac J
    Bord Med; 1972 Jan; 5(1):71-6. PubMed ID: 5012483
    [No Abstract]   [Full Text] [Related]  

  • 31. The concept of dysfunctional uterine bleeding with I.U.C.D.
    Mukherjee K; Dey U; Roy S; Sen P; Banerjee SK
    J Indian Med Assoc; 1967 Jul; 49(1):37-43. PubMed ID: 6074843
    [No Abstract]   [Full Text] [Related]  

  • 32. Reduction by naproxen of excessive menstrual bleeding in women using intrauterine devices.
    Davies AJ; Anderson AB; Turnbull AC
    Obstet Gynecol; 1981 Jan; 57(1):74-8. PubMed ID: 7005780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: a multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment charts.
    Reid PC; Virtanen-Kari S
    BJOG; 2005 Aug; 112(8):1121-5. PubMed ID: 16045528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hysteroscopic findings in women with IUD-induced menorrhagia.
    Lei ZW; Xie L
    Int J Gynaecol Obstet; 1993 Aug; 42(2):173-4. PubMed ID: 7901068
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect of levonorgestrel-releasing intrauterine device on menorrhagia in women taking anticoagulant medication after cardiac valve replacement.
    Kilic S; Yuksel B; Doganay M; Bardakci H; Akinsu F; Uzunlar O; Mollamahutoglu L
    Contraception; 2009 Aug; 80(2):152-7. PubMed ID: 19631790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Menstrual blood loss in women using the frameless FibroPlant LNG-IUS.
    Andrade A; Wildemeersch D
    Contraception; 2009 Feb; 79(2):134-8. PubMed ID: 19135571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of menstrual blood loss in Belgian users of a new T-shaped levonorgestrel-releasing intrauterine system.
    Wildemeersch D; Rowe PJ
    Contraception; 2005 Jun; 71(6):470-3. PubMed ID: 15914139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of prostaglandin synthetase inhibitors in gynaecology.
    Anderson AB
    Practitioner; 1981 Oct; 225(1360):1460-70. PubMed ID: 6799953
    [No Abstract]   [Full Text] [Related]  

  • 39. Experience with intra-uterine contraceptive device at a local health authority clinic.
    Mowat J; Johnstone AB
    Health Bull (Edinb); 1974 Jan; 32(1):35-7. PubMed ID: 4846023
    [No Abstract]   [Full Text] [Related]  

  • 40. Experience with polyethylene ring: 1955-1965. 2.
    Sakurabayashi M
    Yokohama Med Bull; 1966 Dec; 17(6):209-21. PubMed ID: 5983543
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.